TrialAutopsyBuilt by Jawad Momani (Pwnedl0l)

Autopsy report · NCT05091684

Administration of Fibrinogen Concentrate for Refractory Bleeding

Cause of deathSlow enrollment Automatic label, confidence 0.5, unverified. How labels are made.
“Only one patient was included in this study due to overly restrictive inclusion and exclusion criteria.”

The sponsor’s own words in the registry.

Life of this trial

2021202220232024Registered2021-10-13Started2022-02-10Primary completion2023-05-25Stopped2023-06-27

Vital statistics

Status
Terminated
Phase
Phase 2
Sponsor
Centre Hospitalier Universitaire de Saint Etienne
Sponsor type
University, hospital or other
Conditions
Hematological Patients; Bleeding; Platelet Refractoriness
Interventions
Fibrinogen Concentrate Human
Participants
1
Sites
1
Countries
France

Trials that died the same way

Look deeper

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.